Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A placebo randomized controlled study to test the efficacy and safety of GNbAC1, a monoclonal antibody for the treatment of multiple sclerosis - Rationale and design.
Serum concentration of CD40L is elevated in inflammatory demyelinating diseases.
CellCept (Product Insert)
Severe tumefactive rebound of multiple sclerosis following fingolimod cessation.
Lumican negatively controls the pathogenicity of murine encephalitic TH17 cells.
Favorable outcome of a pregnancy after fampridine exposition during the first month.
Age-related changes in the function and structure of the peripheral sensory pathway in mice.
Osmotic Demyelination Syndrome Presenting with Chorea.
Explaining fatigue in multiple sclerosis: cross-validation of a biopsychosocial model.
Enabling specialist nurses to prove their value.
Neuromyelitis Optica Spectrum Disorders.
Disrupted topological organization of structural and functional brain connectomes in clinically isolated syndrome and multiple sclerosis.
Late-onset myasthenia gravis. Follow-up of 113 patients diagnosed after age 60.
Remyelination researchers regroup after proof-of-concept setback in multiple sclerosis.
Dilutional Hyponatremia during Hysteroscpic Surgery: Prevention and Treatment.
Multiple Sclerosis in Pediatrics: Current Concepts and Treatment Options.
A neurophysiological study of facial numbness in multiple sclerosis: Integration with clinical data and imaging findings.
Transverse myelitis-like presentation of methanol intoxication: A case report and review of the literature.
Comparison of Percutaneous Retrogasserian Balloon Compression and Gamma Knife Radiosurgery for the Treatment of Trigeminal Neuralgia in Multiple Sclerosis.
Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
Peripheral Nerve Ultrasonography in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy: Correlations with Clinical and Neurophysiological Data.
Immunotherapy Improves Cognitive Function in Secondary Progressive Multiple Sclerosis.
Genetic analysis of inflammation, cytokine mRNA expression and disease course of relapsing experimental autoimmune encephalomyelitis in DA rats.
GDNF Enhances Therapeutic Efficiency of Neural Stem Cells-Based Therapy in Chronic Experimental Allergic Encephalomyelitis in Rat.
Other noninfectious inflammatory disorders.
Pages
« first
‹ previous
…
755
756
757
758
759
760
761
762
763
…
next ›
last »